Plasma and serum levels of D-dimer and their correlations with other hemostatic parameters in pregnancy

Thrombosis Research

Volumn 105, Issue 3, 2002, Pages 257-262

  Paniccia, Rita ^a   Prisco, Domenico ^a,b   Bandinelli, Brunella ^a   Fedi, Sandra ^a,b   Giusti, Betti ^a,b   Pepe, Guglielmina ^c   Abbate, Rosanna ^a,b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Coagulation; D dimer; Fibrinolysis; Pregnancy; Serum

Indexed keywords

D DIMER;

ADULT; ARTICLE; BLOOD CLOTTING; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION ANALYSIS; EUGLOBULIN LYSIS TEST; FEMALE; FIBRIN DEPOSITION; FIBRINOLYSIS; HUMAN; IN VITRO STUDY; NORMAL HUMAN; PREGNANCY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HEMOSTASIS; HUMANS; PREGNANCY;

EID: 0036473795     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(02)00022-1     Document Type: Article

References (40)

1. Sodium acetate buffer. A diluent of choice in the clot lysis time technique
2. Evaluation of euglobulin methods for the study of blood fibrinolytic activity: Results for patients with rheumatoid arthritis and in postoperative period
3. Euglobulin lysis time in fresh and stored samples
4. Diagnosis of disseminated intravascular coagulation. Role of D-dimer
5. Diagnostic efficacy of the D-dimer assay in disseminated intravascular coagulation (DIC)
6. Plasma measurement of D-dimer as diagnostic aid in suspected venous thromboembolism: An overview
7. Unreliability of current serum fibrin degradation product (FDP) assay
8. Global fibrinolytic capacity assessed by the s-DD test. Correlation between basal and stimulated values
9. A novel principle for assessment of stimulated fibrinolysis
10. D-dimer test after standardized coagulation. A new assay for global evaluation of the unstimulated fibrinolytic system
11. Effect of temperature and incubation time on D-dimer serum levels in healthy subjects
12. Haemostasis in normal pregnancy
13. Fibrinolysis during normal human pregnancy: Complex inter-relationship between plasma levels of tissue plasminogen activator and inhibitors and the euglobulin clot lysis time
14. Enhanced thrombin generation and fibrinolytic activity in normal pregnancy and the puerperium
15. Coagulation and fibrinolysis parameters in normal pregnancy and in gestational diabetes
16. Coagulation and fibrinolytic parameters in normal pregnancy and in pregnancy complicated by intrauterine growth retardation
17. Markers of intravascular coagulation and fibrinolysis in preeclampsia: Association with intrauterine growth retardation
18. Tissue factor levels and high ratio of fibrinopeptide A: D-dimer as a measure of endothelial procoagulant disorder in pre-eclampsia
19. A longitudinal study of the relationships between haemostatic, lipid and oestradiol changes during normal pregnancy
20. Maternal plasma D-dimer levels in normal and complicated pregnancies
21. Blood clotting activation during normal pregnancy
22. Evaluation of six markers of hemostatic system in normal pregnancy and pregnancy complicated by hypertension or pre-eclampsia
23. D-dimer plasma levels during normal pregnancy measured by specific ELISA
24. Fibrinolysis changes in normal pregnancy
25. TAFI antigen and D-dimer levels during normal pregnancy and at delivery
26. Endothelial cell markers and fibrinopeptide A to D-dimer ratio as a measure of coagulation and fibrinolysis balance in normal pregnancy
27. An immunoassay for human D dimer using monoclonal antibody
28. Determination of human prothrombin activation fragment 1+2 in plasma with an antibody against a synthetic peptide
29. Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay
30. Methodological study and a recommended technique for determining the euglobulin lysis time
31. Evidence for a rapid inhibitor to tissue plasminogen activator in plasma
32. Sandwich ELISA for t-PA antigen employing a monoclonal antibody
33. Measurement of plasminogen activator inhibitor 1 (PAI-1) in biological fluids with a murine monoclonal antibody based enzyme-linked immunoabsorbent assay
34. Standards in fibrinolysis. Current status and future challenges
35. Plasma assays for derivatives of fibrin and of fibrinogen, based on monoclonal antibodies
36. Plasminogen activator inhibitor-1 is the primary inhibitor of tissue-type plasminogen activator in pregnancy plasma
37. Fibrinolysis in pregnancy: A study of plasminogen activation inhibitors
38. APC resistance and other haemostatic variables during pregnancy and puerperium
39. Hemostasis in the uteroplacental and peripheral circulations in normotensive and pre-eclamptic pregnancies
40. Latex-enhanced immunoturbidimetry allows D-dimer determination in plasma and serum samples